Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Current Deferred Revenue (2016 - 2022)

Nutex Health (NUTX) has disclosed Current Deferred Revenue for 9 consecutive years, with $92111.0 as the latest value for Q1 2022.

  • For Q1 2022, Current Deferred Revenue rose 71.09% year-over-year to $92111.0; the TTM value through Mar 2022 reached $92111.0, up 71.09%, while the annual FY2021 figure was $173919.0, 126.79% up from the prior year.
  • Current Deferred Revenue hit $92111.0 in Q1 2022 for Nutex Health, down from $173919.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $173919.0 in Q4 2021 and bottomed at $600.0 in Q3 2019.
  • Average Current Deferred Revenue over 5 years is $52588.6, with a median of $40217.0 recorded in 2020.
  • Year-over-year, Current Deferred Revenue crashed 85.6% in 2019 and then surged 2743.67% in 2020.
  • Nutex Health's Current Deferred Revenue stood at $4167.0 in 2018, then soared by 3873.12% to $165560.0 in 2019, then tumbled by 53.68% to $76687.0 in 2020, then surged by 126.79% to $173919.0 in 2021, then tumbled by 47.04% to $92111.0 in 2022.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $92111.0, $173919.0, and $45022.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.